Switzerland· 60722001
Filgrastim-Teva
A filgrastim product containing filgrastimum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Filgrastim is registered in 17 of 19 countries.
Countries holding a registration under ATC L03AA02 (filgrastim), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 10 of them publish a price we can compare per daily dose
Filgrastim · ATC L03AA02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- filgrastimum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- L03AA02
- ATC class
- Filgrastim
- Defined daily dose
- 0.35 mg, P
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680607220013Fertigspr 0.5 mlCHF 78.85
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
191 interactions on record for filgrastim.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Filgrastim · interactions on record
191 records
- 2 severe
- 189 moderate
Most severe, free to view
- CladribineL01BB04severe
- CyclophosphamideL01AA01moderate
- ChlorambucilL01AA02moderate
- MelphalanL01AA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Filgrastim in 18 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaACCOFILAccord Healthcare S.L.U., Barcelona
- FinlandAccofilAccord Healthcare S.L.U.
- United StatesFILKRIAccord BioPharma Inc.,
- SpainACCOFIL 12 MU/0,2 ML SOLUCION INYECTABLE Y PARA PERFUSION EN JERINGA PRECARGADAAccord Healthcare S.L.U.
- BelgiumAccofil 12 10*6 U/0.2 mlAccord Healthcare
- PolandAccofilAccord Healthcare S.L.U.
- IrelandAccofil 30 MU/0.5 ml solution for injection/infusion in pre-filled syringeAccord Healthcare S.L.U.
- FranceACCOFIL 12 MU/0,2 ml, solution injectable ou pour perfusion en seringue préremplieACCORD HEALTHCARE (ESPAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Belgium · Neupogen
- Germany · Neupogen
- Spain · Neupogen
- France · Neupogen
- United Kingdom (Northern Ireland) · Neupogen, Neupogen Singleject
- Ireland · Neupogen, Neupogen Singleject
- Iceland · Accofil, Filgrastim Hexal
- Italy · Granulokine
- Liechtenstein · Accofil, Filgrastim Hexal
- Luxembourg · Neupogen
- Netherlands · Neupogen, Neupogen Singleject
- Norway · Accofil, Filgrastim Hexal
- Poland · Neupogen
- Sweden · Neupogen
- Slovenia · Neupogen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cfb7aade-bb65-4ffa-bd31-d7d13d3419a4 GET /v1/drugs/cfb7aade-bb65-4ffa-bd31-d7d13d3419a4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "filgrastimum adnr 30 Mio U",
"valid_from": "2010-03-01",
"limitations": "[{\"description\":\"Anwendung bei erfolgversprechenden, stark myelotoxischen Chemotherapien bei Patienten, die wegen eingeschränkter Knochenmarkreserven besonders infektionsgefährdet sind.<br>\\nFILGRASTIM ist indiziert für die Mobilisierung von Vorläuferzellen des peripheren Blutes (PBPC) vor einer Leukapherese, um bei Patienten mit myelosuppressiver Behandlung durch eine Transplantation solcher Zellen die hämatologische Wiederherstellung zu beschleunigen.<br>\\nSchwere kongenitale Neutropenie (Kostman Syndrom), zyklische Neutropenie, chronische idiopathische Neutropenie (Langzeitanwendung zur Erhöhung der neutrophilen Granulozytenzahl Bereich 1000 bis 3000 Granulozyten pro mcl und Reduktion der Infektionen bei Kindern und Erwachsenen mit klinisch signifikanten Infektionen während der vergangenen 12 Monate und dreimalig dokumentierter schwerster Neutropenie (< 0.5 x 10^9 ANC/l) während 6 Monaten und nach Ausschluss von reaktiv bedingten Neutropenien Vitamin B12 Mangel, Autoimmunkrankheiten).\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2010-03-01\",\"validTo\":null}]",
"galenic_form": "Inj Lös 30 Mio E/0.5ml",
"therapeutic_area": null,
"sl_inclusion_date": "2010-03-01",
"self_retention_pct": 10
}See everything about filgrastim.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.